Skip to search formSkip to main contentSkip to account menu

LMP 420

Known as: LMP-420, LMP420 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells
B-cell chronic lymphocytic leukemia (CLL) is characterized by slow accumulation of malignant cells, which are supported in the… 
2009
2009
The Anti-Inflammatory Investigational Agent LMP-420 Demonstrates in Vitro Cytotoxic Activity against Chronic Lymphocytic Leukemia Cells.
Abstract 2358 Poster Board II-335 Background: Chronic Lymphocytic Leukemia (CLL) is a common incurable hematologic malignancy… 
2006
2006
LMP-420, un nouvelle approche thérapeutique pour le paludisme cérébral ?
2006
2006
LMP-420, un nouvelle approche thrapeutique pour le paludisme crbral ?
1. Wessman M, Kaunisto M, Kallela M, Palotie A. The molecular genetics of migraine. Ann Med 2004 ; 36 : 462-73. 2. Dichgans M… 
2006
2006
LMP-420, approche thérapeutique le paludisme cérébral ?
2005
2005
A Tool to Estimate the Risks of Repeat Cesarean Section
2005
2005
Targeting of Endothelial Activation in Cerebral Malaria
2005
2005
Getting More Mileage from Lymph Node Biopsies
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)